#USA #New York #Class Action #Levi & Korsinsky #aTyr Pharma

Deadline Approaches for ATYR Class Action Lawsuit

As the deadline approaches, investors in aTyr Pharma, Inc. (NASDAQ: ATYR) are urged to consider participation in a class action lawsuit initiated by Levi & Korsinsky, LLP. This action aims to seek recovery for those adversely affected by an alleged securities fraud that transpired between November 7, 2024, and September 12, 2025.

Key Details of the Class Action

The legal representation asserts that the defendants engaged in a pattern of misleading actions and statements about the efficacy of its drug, Efzofitimod. While publicly portraying optimism, they allegedly concealed essential information that would have informed investors of the drug's shortcomings, particularly its inability to help patients fully taper off steroid usage. The pivotal moment arrived on September 15, 2025, when aTyr revealed that the EFZO-FIT trial did not achieve its primary endpoint—a significant announcement that led to substantial stock price plummeting.

Following the company’s revelation, aTyr's stock price fell drastically, plunging 83.2% from $6.03 to $1.02 within a single trading day. This steep decline highlights the impact of the company’s allegedly misleading communications, calling into question the integrity of the information that was shared with investors.

Your Rights as an Investor

Potential participants in the class action have until December 8, 2025, to submit a request to be appointed as lead plaintiff in the case. Importantly, involvement in the case does not necessitate serving as a lead plaintiff to qualify for any potential compensation. If you suffered losses in aTyr during the outlined period, contacting Levi & Korsinsky could provide a pathway to recovery.

No Cost to Class Members

The firm emphasizes that there is no upfront cost or out-of-pocket expense to participate in the lawsuit. Class members may be entitled to compensation without any financial burden, making it an accessible option for those affected.

About Levi & Korsinsky

With over 20 years of experience in securities litigation, Levi & Korsinsky has established a robust reputation, securing hundreds of millions of dollars for investors. The firm has a dedicated team of over 70 professionals who are seasoned in representing clients in complex class action cases. Their longstanding track record includes recognition as one of the top securities litigation firms in the United States as noted in ISS Securities Class Action Services’ reports.

Investors wishing to learn more about the aTyr class action or to initiate their participation can reach out to the firm directly. Key contact details include:

• - Email: [email protected]
• - Phone: (212) 363-7500
• - Website: www.zlk.com

Conclusion

For aTyr investors, this is a critical time to act as the deadline for participation in the class action suit approaches. Understanding your rights and options is crucial, and having the guidance of experienced legal counsel can be invaluable in navigating these complex situations.